menu
    • menu

    Company profile for Palatin Technologies

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Palatin Technologies, Inc. (NYSE American: PTN) is a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Our product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Vyleesi™, the trade name for Br...
    Palatin Technologies, Inc. (NYSE American: PTN) is a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Our product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Vyleesi™, the trade name for Bremelanotide, for the treatment of hypoactive sexual desire disorder (HSDD) is our lead product. A New Drug Application for approval of Vyleesi was approved by the Food and Drug Administration (FDA) in June 2019.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Palatin TechnologiesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4-B Cedar Brook Drive Cedar Brook Corporate Center Cranbury, NJ 08512
    Telephone
    Telephone
    1-609-495-2200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://palatin.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Palatin Reveals Q1 Fy2026 Financials And Corporate Progress
    Palatin Reveals Q1 Fy2026 Financials And Corporate Progress

    13 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/palatin-reports-first-quarter-fiscal-year-2026-financial-results-and-provides-corporate-update-302614162.html

    PR NEWSWIRE
    13 Nov 2025
    Share Share
    Palatin Technologies Closes $18.2M Upsized Offering
    Palatin Technologies Closes $18.2M Upsized Offering

    12 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/palatin-technologies-announces-closing-of-upsized-18-2-million-public-offering-with-the-full-exercise-of-the-underwriters-over-allotment-option-302613372.html

    PR NEWSWIRE
    12 Nov 2025
    Share Share
    Palatin Pharma Sets $15.8M Public Offering Price
    Palatin Pharma Sets $15.8M Public Offering Price

    06 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/palatin-technologies-announces-pricing-of-upsized-15-8-million-public-offering-302606870.html

    PR NEWSWIRE
    06 Nov 2025
    Share Share
    Palatin Unveils Melanocortin Therapy Data at ENDO 2025
    Palatin Unveils Melanocortin Therapy Data at ENDO 2025

    06 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/palatin-presents-data-at-obesityweek-2025-highlighting-promise-of-melanocortin-based-therapies-for-obesity-302606887.html

    PR NEWSWIRE
    06 Nov 2025
    Share Share
    Palatin Gets €5.5M Milestone In Retinal Deal With Boehringer
    Palatin Gets €5.5M Milestone In Retinal Deal With Boehringer

    22 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/palatin-earns-5-5-million-6-5-million-milestone-payment-in-retinal-disease-collaboration-with-boehringer-ingelheim-302562035.html

    PR NEWSWIRE
    22 Sep 2025
    Share Share
    Boehringer, Palatin to Develop Novel Retinal Disease Treatment
    Boehringer, Palatin to Develop Novel Retinal Disease Treatment

    18 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/18/3135002/0/en/Boehringer-Ingelheim-and-Palatin-Technologies-to-develop-potential-first-in-class-melanocortin-receptor-targeted-treatment-for-patients-with-retinal-diseases.html

    GLOBENEWSWIRE
    18 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search